DB and DK contributed to the work equally. Background Extracorporeal photopheresis
(ECP) is a recommended second or later line of therapy for chronic GVHD (cGVHD), and is …

Background Extracorporeal photopheresis (ECP) is recommended as a second-or later-line
therapy for chronic GvHD (cGvHD). Benefits include reasonable response with avoidance of …

Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

Recently, Pidala and Anasetti [1] presented a review on glucocorticoid-refractory acute graft-
versus-host disease (aGVHD), which included options for salvage therapies and future …

Background: ECP is often used to treat chronic GVHD (cGVHD) despite an unclear
mechanism of action. The NIH Consensus Criteria (2005) addressed grading of cGVHD and …

Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …

BACKGROUND Extracorporeal photopheresis (ECP) is a recognized second‐line treatment
for steroid‐refractory chronic graft‐versus‐host disease (cGVHD). Treatment course is …

The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …